ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.885
      0.12%
      Bitcoin
      64,910.68
      -0.35%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX
      6. Mast Therapeutics, Inc. (ANX)

      7. Mast Therapeutics, Inc. (ANX) News

      ANX

      Adventrx (ANX)

      Mast Therapeutics, Inc.
      		Date:
      Sort by:
       Showing the most relevant articles for your search:AMEX:ANX
      DateTimeSourceHeadlineSymbolCompany
      12/19/20124:18PMEdgar (US Regulatory)Current report filing (8-K)AMEX:ANXMast Therapeutics, Inc.
      12/19/20128:00AMPR Newswire (US)ADVENTRX To Initiate Phase 3 Study Of ANX-188AMEX:ANXMast Therapeutics, Inc.
      12/07/20124:09PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:ANXMast Therapeutics, Inc.
      12/03/20128:30AMPR Newswire (US)ADVENTRX Announces Launch Of New Corporate WebsiteAMEX:ANXMast Therapeutics, Inc.
      11/05/20125:03PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:ANXMast Therapeutics, Inc.
      11/05/201211:10AMEdgar (US Regulatory)Current report filing (8-K)AMEX:ANXMast Therapeutics, Inc.
      11/05/201211:10AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:ANXMast Therapeutics, Inc.
      11/05/20128:00AMPR Newswire (US)ADVENTRX Reports Third Quarter 2012 Financial ResultsAMEX:ANXMast Therapeutics, Inc.
      10/25/20124:05PMPR Newswire (US)ADVENTRX Announces Details Of The Phase 3 Study Of ANX-188AMEX:ANXMast Therapeutics, Inc.
      10/23/20128:30AMPR Newswire (US)ADVENTRX Announces Conference Call To Review Protocol For Phase 3 Clinical Study Of ANX-188AMEX:ANXMast Therapeutics, Inc.
      10/02/20128:00AMPR Newswire (US)ADVENTRX Engages Theradex Systems, Inc. to Manage Phase 3 Clinical Study of ANX-188AMEX:ANXMast Therapeutics, Inc.
      09/07/20121:00PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANXMast Therapeutics, Inc.
      09/07/201212:58PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:ANXMast Therapeutics, Inc.
      09/07/201210:37AMEdgar (US Regulatory)Current report filing (8-K)AMEX:ANXMast Therapeutics, Inc.
      09/07/20128:00AMPR Newswire (US)ADVENTRX Announces Appointment Of Ted W. Love M.D. To Board Of DirectorsAMEX:ANXMast Therapeutics, Inc.
      09/05/20127:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANXMast Therapeutics, Inc.
      09/05/20127:18PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:ANXMast Therapeutics, Inc.
      08/28/20128:00AMPR Newswire (US)ADVENTRX Pharmaceuticals To Present At The Rodman & Renshaw Annual Global Investment Conference On September 10AMEX:ANXMast Therapeutics, Inc.
      08/14/20128:00AMPR Newswire (US)ADVENTRX Announces Appointment Of Chief Medical OfficerAMEX:ANXMast Therapeutics, Inc.
      08/06/201211:51AMEdgar (US Regulatory)Current report filing (8-K)AMEX:ANXMast Therapeutics, Inc.
      08/06/20128:00AMPR Newswire (US)ADVENTRX Reports Second Quarter 2012 Financial ResultsAMEX:ANXMast Therapeutics, Inc.
      07/30/20127:48PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANXMast Therapeutics, Inc.
      07/30/20127:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANXMast Therapeutics, Inc.
      07/30/20127:45PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANXMast Therapeutics, Inc.
      07/26/20128:00AMPR Newswire (US)ADVENTRX Pharmaceuticals to Present at 1st Annual Sickle Cell Disease Therapeutics ConferenceAMEX:ANXMast Therapeutics, Inc.
      07/09/20128:00AMPR Newswire (US)ADVENTRX Pharmaceuticals To Present At The OneMedForum New York 2012 Emerging Company Finance Conference On July 12AMEX:ANXMast Therapeutics, Inc.
      06/26/20128:00AMPR Newswire (US)ADVENTRX Announces Manufacturing Agreement With Patheon to Manufacture ANX-188 Drug ProductAMEX:ANXMast Therapeutics, Inc.
      06/21/20124:11PMEdgar (US Regulatory)Current report filing (8-K)AMEX:ANXMast Therapeutics, Inc.
      06/18/20128:00AMPR Newswire (US)ADVENTRX Pharmaceuticals To Present At 2012 BIO International Convention Business ForumAMEX:ANXMast Therapeutics, Inc.
      06/12/20128:00AMPR Newswire (US)ADVENTRX And Pierre Fabre Announce Manufacturing Agreement For ANX-188 Drug SubstanceAMEX:ANXMast Therapeutics, Inc.
       Showing the most relevant articles for your search:AMEX:ANX